Neonatal outcomes after gestational exposure to nitrofurantoin

Obstetrics and Gynecology

Volumn 121, Issue 2 PART 1, 2013, Pages 306-313

  Nordeng, Hedvig ^a,b,c   Lupattelli, Angela ^a,b,c   Romøren, Maria ^a,b,c   Koren, Gideon ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN; PIVMECILLINAM;

ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DATA BASE; DELIVERY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; LIVE BIRTH; MAJOR CLINICAL STUDY; NEWBORN JAUNDICE; NEWBORN PERIOD; NORWAY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; STILLBIRTH; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-INFECTIVE AGENTS, URINARY; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NITROFURANTOIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84873867412     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31827c5f88     Document Type: Article

References (20)

1. Delzell JJ, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713-21.
2. Smaill F, Vazquez J. Antibiotics for asymptomatic bacteriuria in pregnancy. The Cochrane Database of Systematic Reviews 2007, Issue 2. Art No: CD000490. DOI: 10.1002/14651858. CD000490.pub2.
3. Christensen B. Use of antibiotics to treat bacteriuria of pregnancy in the Nordic countries. Which antibiotics are appropriate to treat bacteriuria of pregnancy? Int J Antimicrob Agents 2001;17:283-5.
4. Cunha BA. Nitrofurantoin: an update. Obstet Gynecol Surv 1989;44:399-406.
5. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009;163:978-85.
6. Ben David S, Einarson T, Ben David Y, Nulman I, Pastuszak A, Koren G. The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol 1995;9: 503-7.
7. Gardner JS, Guyard-Boileau B, Alderman BW, Fernbach SK, Greene C, Mangione EJ. Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis. Int J Epidemiol 1998;27:64-7.
8. Kallen BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255-61.
9. Kallen B, Robert-Gnansia E. Maternal drug use, fertility problems, and infant craniostenosis. Cleft Palate Craniofac J 2005; 42:589-93.
10. Powel R. Nitrofurantoin-induced hemolysis. J Lab Clin Med 1963;163:978-85.
11. WHO Collaborating Centre for Drug Statistics methodology. Guidelines for ATC classification and DDD assignment. Geneva (Switzerland): World Health Organization; 2011.
12. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available at: http://apps.who.int/classifications/icd10/ browse/2010/en. Retrieved June 9, 2012.
13. Report of variable definitions in the Medical Birth Registry of Norway-Part I. Oslo (Norway): The Norwegian Institute of Public Health; 2011.
14. Bratlid D, Nakstad B, Hansen TW. National guidelines for treatment of jaundice in the newborn. Acta Paediatr 2011; 100:499-505.
15. Sulfonamides, nitrofurantoin, and risk of birth defects. Committee Opinion No. 494. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:1484-5.
16. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010;66:207-14.
17. Hailey F, Fort H, Williams J, Hammers B. Foetal safety of nitrofurantoin macrocrystals therapy during pregnancy: a retrospective analysis. J Int Med Res 1983;11:364-9.
18. Gait JE. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990;24:1210-3.
19. Kubon C, Sivertsen A, Vindenes HA, Abyholm F, Wilcox A, Lie RT. Completeness of registration of oral clefts in a medical birth registry: a population-based study. Acta Obstet Gynecol Scand 2007;86:1453-7.
20. Melve KK, Lie RT, Skjaerven R, Van Der Hagen CB, Gradek GA, Jonsrud C, et al. Registration of Down syndrome in the Medical Birth Registry of Norway: validity and time trends. Acta Obstet Gynecol Scand 2008;87:824-30.